Abstract LB-77: A randomized double-blind placebo-controlled phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small cell lung cancer: Correlative analyses

2010 ◽  
Author(s):  
David R. Spigel ◽  
Howard A. Burris ◽  
F. Anthony Greco ◽  
Diana L. Shipley ◽  
Elke K. Friedman ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Previously Treated

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer

2007 ◽  
Vol 61 (3) ◽  
pp. 503-508 ◽  
Author(s):  
Fumiyoshi Ohyanagi ◽  
Atsushi Horiike ◽  
Yoshio Okano ◽  
Yukitoshi Satoh ◽  
Sakae Okumura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated Patients ◽  
Previously Treated

scholarly journals 1389P IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced non-small cell lung cancer (NSCLC)

2020 ◽  
Vol 31 ◽  
pp. S882-S883 ◽  
Author(s):  
A. Lavole ◽  
J. Mazieres ◽  
S. Schneider ◽  
S. Brosseau ◽  
L.M. Kiakouama ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Hiv Patients ◽  
Previously Treated

A phase II trial of denileukin difititox–in previously treated, advanced non-small cell lung cancer (NSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7292-7292
Author(s):  
M. A. Gerena Lewis ◽  
R. Shukla ◽  
B. Kleykamp ◽  
A. R. Jazieh ◽  
J. Hainsworth
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document